Literature DB >> 34006835

Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.

ChangDong Lin1, Yue Li1, YueBin Zhang2, ZhaoYuan Liu1, Xia Mu2, Chenjian Gu3,4, Jing Liu3,4, Yutang Li3,4, GuoHui Li5, JianFeng Chen6,7.   

Abstract

Entities:  

Year:  2021        PMID： 34006835     DOI： 10.1038/s41392-021-00619-y

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  9 in total

1.  Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.

Authors:  Henry R O'Donnell; Tia A Tummino; Conner Bardine; Charles S Craik; Brian K Shoichet
Journal:  J Med Chem       Date:  2021-11-23       Impact factor: 7.446

Review 2.  An outlook on potential protein targets of COVID-19 as a druggable site.

Authors:  Rubia Noori; Meryam Sardar
Journal:  Mol Biol Rep       Date:  2022-07-06       Impact factor: 2.742

3.  In silico screening of some compounds derived from the desert medicinal plant Rhazya stricta for the potential treatment of COVID-19.

Authors:  Nabih A Baeshen; Abdulaziz O Albeshri; Naseebh N Baeshen; Roba Attar; Alaa Karkashan; Basma Abbas; Thamer A Bouback; Abdullah A Aljaddawi; Mohammed Y Refai; Hayam S Abdelkader; Abdullah Al Tamim; Abdullah Alowaifeer; Firoz Ahmed; Mohammed N Baeshen
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

4.  Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.

Authors:  Lipika R Pal; Kuoyuan Cheng; Nishanth Ulhas Nair; Laura Martin-Sancho; Sanju Sinha; Yuan Pu; Laura Riva; Xin Yin; Fiorella Schischlik; Joo Sang Lee; Sumit K Chanda; Eytan Ruppin
Journal:  iScience       Date:  2022-04-27

Review 5.  SARS-CoV-2 cell entry and targeted antiviral development.

Authors:  Zinuo Chen; Ruikun Du; Jazmin M Galvan Achi; Lijun Rong; Qinghua Cui
Journal:  Acta Pharm Sin B       Date:  2021-05-13       Impact factor: 11.413

6.  Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.

Authors:  Lipika R Pal; Kuoyuan Cheng; Nishanth Ulhas Nair; Laura Martin-Sancho; Sanju Sinha; Yuan Pu; Laura Riva; Xin Yin; Fiorella Schischlik; Joo Sang Lee; Sumit K Chanda; Eytan Ruppin
Journal:  bioRxiv       Date:  2021-09-15

7.  Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study.

Authors:  Ahmad F Eweas; Hosam-Eldin H Osman; Ibrahim A Naguib; Mohammed A S Abourehab; Ahmed S Abdel-Moneim
Journal:  Curr Issues Mol Biol       Date:  2022-07-04       Impact factor: 2.976

Review 8.  Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis.

Authors:  Zhongyun Zhang; Juan Zhang; Jiqiu Wang
Journal:  Front Public Health       Date:  2022-08-24

Review 9.  Pharmacological therapies and drug development targeting SARS-CoV-2 infection.

Authors:  Yizhou Jiang; Limor Rubin; Zhiwei Zhou; Haibo Zhang; Qiaozhu Su; Sheng-Tao Hou; Philip Lazarovici; Wenhua Zheng
Journal:  Cytokine Growth Factor Rev       Date:  2022-10-13       Impact factor: 17.660
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.